Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
James L. Januzzi, Stefano Del Prato, Julio Rosenstock, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9

Showing 9 citing articles:

Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
James L. Januzzi, Javed Butler, Stefano Del Prato, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 2, pp. 137-148
Closed Access | Times Cited: 8
Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing Subanalysis
W.H. Wilson Tang, Yuxi Liu, Javed Butler, et al.
Circulation Heart Failure (2025)
Closed Access
The role and therapeutic potential of macrophages in the pathogenesis of diabetic cardiomyopathy
Shan Zhang, Xueying Zhu, Yupeng Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference
Kartik Gupta, Bharat Rawlley, Chelsea Meloche, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 8, pp. 367-381
Closed Access | Times Cited: 2
Diabetic cardiomyopathy: Emerging therapeutic options
Cornelius James Fernandez, Sahana Shetty, Joseph M. Pappachan
World Journal of Diabetes (2024) Vol. 15, Iss. 8, pp. 1677-1682
Open Access | Times Cited: 2
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies.
Vincenzo Rizza, Lara Tondi, Angelo Maria Patti, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2024) Vol. 23, pp. 200338-200338
Open Access | Times Cited: 1
Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial
Laibah Arshad Khan, Muhammad Shahzeb Khan, Andrew P. Ambrosy, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 5, pp. 1157-1160
Closed Access
Subclinical Left Ventricular Dysfunction over Seven-Year Follow-Up in Type 2 Diabetes Patients without Cardiovascular Diseases
Д. У. Акашева, T. G. Utina, О Н Джиоева, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2031-2031
Open Access
Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies
Chun-Yao Cheng, Wen‐Rui Hao, Ju‐Chi Liu, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 12, pp. 2370-2375
Closed Access
Page 1

Scroll to top